Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inbox Gmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscription Click this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Just For You Notable Newcomers: These 2025 IPOs Dominated the YearSubmitted by Leo Miller. Date Posted: 1/2/2026. In 2025, more than 200 companies completed initial public offerings (IPOs) on U.S. exchanges, yet fewer than one-quarter outperformed the S&P 500's 18% return. Below, we break down three 2025 IPOs that stood out by attracting significant investor interest and comfortably beating the market. Implied upside and downside data are as of the Jan. 2 close. KRMN Delivers More Than Triple-Bagger Performance in 2025 First up is defense stock Karman (NYSE: KRMN). The stock went public on Feb. 12, 2025, at $22 per share and finished the year just above $73, delivering a return of more than 230%. Karman's revenue growth accelerated each quarter in 2025, with 42% growth in the most recent quarter, roughly double the 21% growth rate seen in Q1. A new trading briefing is drawing attention to a little-discussed policy-driven market theme some traders believe could create short-term opportunities.
In a recent video, a veteran technical analyst walks through how this setup works, why it's showing unusual momentum, and how active traders are approaching it using defined, time-bound strategies rather than long-term buy-and-hold positions. Watch the trading briefing here Article Highlights - While hundreds of companies went public in 2025, three key names delivered especially impressive performances.
- KRMN, CRCL, and HNGE delivered returns between 40% and more than 200%.
- Analysts continue to see upside in these stocks, but to varying degrees.
Karman supplies mission-critical components to nearly every prime defense contractor in the U.S. space and defense market. Those firms rely on Karman's technology for high-growth areas such as hypersonic missiles, and the company's proprietary products give it meaningful pricing power. Karman's strong gross margin of 41% last quarter ranked among the top five for mid-cap or larger U.S. aerospace and defense stocks. The MarketBeat consensus price target for Karman is $80.43, implying roughly 5% upside. While that appears modest after the stock's substantial run, it is notable that analysts still see additional upside. Stablecoin Stock CRCL Rises 150% in Seven Months Next is Circle Internet Group (NYSE: CRCL). The company went public on June 5, 2025, at $31. By year-end, shares were trading just above $79, a gain of more than 150%. Circle is a stablecoin issuer; stablecoins are cryptocurrencies pegged to a relatively stable asset such as the U.S. dollar, providing many blockchain benefits without the volatility of other digital assets. Use cases include faster, lower-cost payments versus traditional methods. A large portion of Circle's 2025 gain occurred on its first trading day, when shares closed above $83, jumping sharply from the IPO price. Last quarter, Circle reported rapid growth, with total revenue up 66% and circulation of its USD Coin rising 108% to $73.7 billion. Analysts remain broadly bullish. The MarketBeat consensus price target of $141.18 suggests about 69% upside. However, targets updated after the company's Nov. 12 earnings report are more tempered, averaging roughly $101 (about 21% upside) and ranging widely from about $60 to $190. Analysts Eye +40% Upside in HNGE After Strong 2025 Finally, Hinge Health (NYSE: HNGE) delivered an impressive 2025. The stock went public on May 22 at $32 and closed the year near $46.50, gaining roughly 45%. Hinge aims to reduce healthcare costs tied to physical therapy through a mobile app and an FDA-cleared wearable. These tools provide patients with personalized physical therapy exercises they can do at home, reducing the need for in-person sessions. Based on 2024 data, Hinge reported that its platform reduced hours spent with human care teams by 95% versus traditional physical therapy. Last quarter, the firm reported revenue growth of 53%, and its free cash flow margin nearly doubled to 53% from 27% a year earlier. Hinge served 2,560 organizational clients, including corporations and government entities. The MarketBeat consensus price target of just under $60 implies about 32% upside. Price targets updated after the company's Nov. 4 earnings report are even more bullish, averaging $67 and implying roughly 47% upside. Watchlist Addition: Hinge Health Overall, 2025 was kind to KRMN, CRCL, and HNGE. Hinge Health is particularly noteworthy: revenue is growing quickly, and free cash flow margins nearly doubled last year. Hinge's product addresses a major U.S. economic issue—high healthcare costs—and with a forward price-to-earnings ratio near 30x, it could see further gains in 2026. That said, the key question remains whether Hinge can sustain its growth and margins over time.
|
Post a Comment
Post a Comment